Literature DB >> 15712079

Methicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic, and therapeutic odyssey.

Stan Deresinski1.   

Abstract

Methicillin-resistant Staphylococcus aureus, first identified just over 4 decades ago, has undergone rapid evolutionary changes and epidemiologic expansion. It has spread beyond the confines of health care facilities, emerging anew in the community, where it is rapidly becoming a dominant pathogen. This has led to an important change in the choice of antibiotics in the management of community-acquired infections and has also led to the development of novel antimicrobials.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15712079     DOI： 10.1086/427701

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  115 in total

1.  Use of Oral Doxycycline for Community-acquired Methicillin-resistant Staphylococcus aureus (CA-MRSA) Infections.

Authors:  Sanjay Bhambri; Grace Kim
Journal:  J Clin Aesthet Dermatol       Date:  2009-04

2.  Patients with methicillin-resistant Staphylococcus aureus infection: twenty-first century lepers.

Authors:  K L Mozzillo; N Ortiz; L G Miller
Journal:  J Hosp Infect       Date:  2010-03-16       Impact factor: 3.926

3.  Antimicrobial susceptibilities of health care-associated and community-associated strains of methicillin-resistant Staphylococcus aureus from hospitalized patients in Canada, 1995 to 2008.

Authors:  Andrew E Simor; Lisa Louie; Christine Watt; Denise Gravel; Michael R Mulvey; Jennifer Campbell; Allison McGeer; Elizabeth Bryce; Mark Loeb; Anne Matlow
Journal:  Antimicrob Agents Chemother       Date:  2010-03-15       Impact factor: 5.191

4.  Antistaphylococcal activities of telavancin tested alone and in combination by time-kill assay.

Authors:  Gengrong Lin; Glenn A Pankuch; Lois M Ednie; Peter C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2010-02-16       Impact factor: 5.191

5.  Nasal carriage of Staphylococcus aureus in healthy humans with different levels of contact with animals in Tunisia: genetic lineages, methicillin resistance, and virulence factors.

Authors:  K Ben Slama; H Gharsa; N Klibi; A Jouini; C Lozano; E Gómez-Sanz; M Zarazaga; A Boudabous; C Torres
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-11-11       Impact factor: 3.267

Review 6.  Community-associated methicillin-resistant Staphylococcus aureus in the patient with HIV infection.

Authors:  Kathy Thompson; Francesca Torriani
Journal:  Curr HIV/AIDS Rep       Date:  2006-09       Impact factor: 5.071

7.  Characterization of a strain of community-associated methicillin-resistant Staphylococcus aureus widely disseminated in the United States.

Authors:  Fred C Tenover; Linda K McDougal; Richard V Goering; George Killgore; Steven J Projan; Jean B Patel; Paul M Dunman
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

8.  Painful nodule with induration and spreading erythema.

Authors:  Elizabeth Race; Cindy Berthelot; Jennifer Clay Cather
Journal:  Proc (Bayl Univ Med Cent)       Date:  2005-10

9.  Prevalence of Methicillin Resistant Staphylococcus aureus Carriage amongst Health Care Workers of Critical Care Units in Kasturba Medical College Hospital, Mangalore, India.

Authors:  Radhakrishna M; Monalisa D'Souza; Subbannayya Kotigadde; Vishwas Saralaya K; Shashidar Kotian M
Journal:  J Clin Diagn Res       Date:  2013-12-15

Review 10.  Treatment strategies for methicillin-resistant Staphylococcus aureus infections in pediatrics.

Authors:  Jason G Newland; Gregory L Kearns
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.